Meta‐analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis

Journal of Clinical Apheresis

Volumn 10, Issue 4, 1995, Pages 163-170

  Vamvakas, Eleftherios C ^a   Pineda, Alvaro A ^b   Weinshenker, Brian G ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

course; disability status scale; meta analysis; multiple sclerosis; plasmapheresis; progression; therapeutic plasma exchange

Indexed keywords

AZATHIOPRINE; CORTICOTROPIN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; ODDS RATIO; PLASMA EXCHANGE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0029619264     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.2920100402     Document Type: Article

References (42)

1. Chronic progressive multiple sclerosis: double‐blind controlled trial of plasmapheresis in patients taking immunosuppressive drugs
2. Plasmapheresis and immunosuppressive drug therapy in multiple sclerosis
3. Plasmapheresis in multiple sclerosis: preliminary study
4. Plasmapheresis in multiple sclerosis: correlation of clinical improvement with increased suppressor cell activity in peripheral blood
5. The application of plasmapheresis to multiple sclerosis
6. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis: a pilot study
7. An assessment of plasma exchange in progressive multiple sclerosis (editorial)
8. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone
9. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis
10. Intensive immunosuppression in progressive multiple sclerosis: a randomized threearm study of high‐dose intravenous cyclophosphamide, plasma exchange and ACTH
11. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis
12. Management of neurologic disorders
13. Plasma exchange in chronic progressive multiple sclerosis
14. Cyclophosphamide and plasma exchange in multiple sclerosis (letter)
15. Cyclophos‐phamide and plasma exchange in multiple sclerosis (letter)
16. An overview of current management
17. The peculiar difficulties of therapeutic trials for multiple sclerosis
18. The natural history of multiple sclerosis: a geographically based study. IV. Applications to planning and interpretation of clinical therapeutic trials
19. Intensive immunosuppressive therapy of progressive multiple sclerosis. Results at 3‐year follow‐up of an open study to compare cyclophosphamide alone or combined with plasma exchange and controls.
20. Double‐blind study of true vs. sham plasma exchange in patients treated with immunosup‐pression for acute attacks of multiple sclerosis
21. A double‐blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis
22. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
23. How study design affects outcomes in comparisons of therapy: I
24. The combination of estimates from different experiments
25. Beta blockade during and after myocardial infarction: an overview of the randomized trials
26. Plasmapheresis in progressive multiple sclerosis (letter)
27. Design strategy in multiple sclerosis clinical trials
28. Plasmapheresis in acute episodes of fulminant CNS inflammatory demy‐elination
29. The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial
30. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability
31. The natural history of mulitple sclerosis
32. Accuracy of statistical methods in Transfusion: a review of articles from July/August 1992 through June 1993
33. Controversy in counting and attributing events in clinical trials
34. Plasmapheresis and combined immunosuppressive drug therapy in chronic progressive multiple sclerosis
35. The natural history of multiple sclerosis: a geographically based study. III. Multivariate analysis of predictive factors and models of outcome
36. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group
37. Role of plasmapheresis in acute disseminated (post infectious) encephalomyelitis
38. Plasmapheresis in chronic progressive multiple sclerosis: Pro